Semaglutide or Wegovy belongs to a class of prescription drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists
Preventive Medicine Reports
Accordingly, this mechanism would circumvent the blocking of distinct NMDA receptors in the brainstem that might otherwise increase food intake in response to MK-801
To use Wegovy, follow these steps: Select and clean the injection site: Choose an area of your abdomen (stomach), upper arm, or thigh for the injection site
Consult with a healthcare provider to determine which option best aligns with your lifestyle, schedule, and health trajectory
A full medical evaluation is required to determine suitability, especially for individuals with gastrointestinal disorders, kidney disease, or a history of pancreatitis